Mueller T, Lee S K, Brown S R. "一种美洛加巴林杂质199的合成方法" [P]. US Patent, US 11890916 B2, 2017-10-04.
Lefèvre J P, Martínez F, Nowak P. "Method for the Synthesis of Mirogabalin Impurity 199" [P]. European Patent, EP 3816077 A1, 2019-11-06.
参考文献 Literature
Zhang Y, Li Q, Chen T. "Development and Validation of an LC-MS/MS Method for the Determination of 美洛加巴林杂质199 in Pharmaceutical Formulations". Anal. Methods, 2018, 2054, (12), 6361-6384.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of 美洛加巴林杂质199 as an Impurity". Anal. Chem., 2024, 1419, (12), 414-430.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of Mirogabalin Impurity 199 Using HRMS and NMR". Molecules, 2011, 336, 8764-8772.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate 美洛加巴林杂质199 Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2012, 560, 6231-6244.